- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Dexrazoxane.
Displaying page 1 of 1.
EudraCT Number: 2005-003217-32 | Sponsor Protocol Number: 0006 | Start Date*: 2005-11-08 | |||||||||||
Sponsor Name:AZIENDA USL DI FORLI | |||||||||||||
Full Title: PHASE-II STUDY TO EVALUATE ACTIVITY OF DEXRAZOXANE CARDIOXANE IN ORDER TO PREVENT CARDIAC TOXICITY IN PATIENTS WITH BREAST CANCER AND TREATED WITH ANTHRACYCLINE | |||||||||||||
Medical condition: To evaluate activity of Dexrazoxane in order to prevent cardiac toxicity in patients with breast cancer and treated with anthracycline | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000220-14 | Sponsor Protocol Number: TT 04 | Start Date*: 2006-03-23 | |||||||||||
Sponsor Name:TopoTarget A/S | |||||||||||||
Full Title: A therapeutic and pharmacokinetic study of Savene (dexrazoxane) in the treatment of accidental anthracycline extravasation | |||||||||||||
Medical condition: Accidental extravasation of anthracyclines | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001271-38 | Sponsor Protocol Number: LT 2004 09 | Start Date*: 2006-06-23 |
Sponsor Name:Our Lady's Hospital for Sick Children | ||
Full Title: Intensified pre-operative chemotherapy and radical surgery for HIGH RISK HEPATOBLASTOMA SIOPEL 4 | ||
Medical condition: Hepatoblastoma | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IE (Completed) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000134-30 | Sponsor Protocol Number: I5B-MC-JGDJ | Start Date*: 2015-09-22 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma | |||||||||||||
Medical condition: Advanced or Metastatic Soft Tissue Sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) HU (Ongoing) DE (Prematurely Ended) ES (Ongoing) AT (Completed) FR (Completed) SE (Ongoing) FI (Ongoing) BE (Completed) NL (Ongoing) PL (Completed) GB (GB - no longer in EU/EEA) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016027-62 | Sponsor Protocol Number: GEIS-21 | Start Date*: 2010-02-11 |
Sponsor Name:GRUPO ESPAÑOL DE INVESTIGACION EN SARCOMAS | ||
Full Title: ENSAYO CLÍNICO, FASE II, ABIERTO, NO CONTROLADO, MULTICÉNTRICO Y PROSPECTIVO, DE QUIMIOTERAPIA INTENSIVA, CIRUGÍA Y RADIOTERAPIA EN SARCOMA DE EWING DE NIÑOS Y ADULTOS JÓVENES | ||
Medical condition: Pacientes niños y adultos jóvenes con sarcoma de Ewing | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002943-23 | Sponsor Protocol Number: TT11EU | Start Date*: 2005-10-21 | |||||||||||
Sponsor Name:TopoTarget A/S | |||||||||||||
Full Title: Ensayo clínico en fase I-II de Topotect (dexrazoxano) y dosis altas de etopósido en el tratamiento de pacientes adultos con tumores cerebrales sólidos, primarios o secundarios. | |||||||||||||
Medical condition: Tumores primarios y secundarios del Sistema Nervioso Central y de sus membranas. En MedDRA versión 7.1, dicha indicación está clasificada con el código MedDRA 10029104, correspondiente al SOC 'Neo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001124-20 | Sponsor Protocol Number: GISG-17 | Start Date*: 2018-08-14 | |||||||||||
Sponsor Name:IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest | |||||||||||||
Full Title: Efficacy of Olaratumab and Rechallenge with Doxorubicin in anthracycline pretreated, advanced soft tissue sarcoma patients. An exploratory phase-II study - The OlaReDo Phase II Trial | |||||||||||||
Medical condition: locally advanced (unresectable) or metastatic soft tissue sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.